MedPath

Effects of etelcalcetide and cinacalcet on bone mineral density in patients with secondary hyperparathyroidism

Not Applicable
Recruiting
Conditions
Patients on hemodialysis complicated with secondary hyperparathyroidism
Registration Number
JPRN-UMIN000027453
Lead Sponsor
Matsunami general hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing paticular.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone mineral density (0, 6, 12 months) BAP, TRACP (0, 6, 12 months)
Secondary Outcome Measures
NameTimeMethod
Ca, P, iPTH (once a month)
© Copyright 2025. All Rights Reserved by MedPath